Functional Dyspepsia (FD) is a common, chronic, and potentially serious medical syndrome. Consequently, clinicians must understand this disorder. It is characterised by persistent upper abdominal symptoms with no identifiable structural cause. FD is classified as a Disorder of Gut-Brain Interaction (DGBI). Furthermore, it can induce significant symptoms like weight loss and food aversion in severe cases. This condition may also be associated with increased risks of hospitalisation and death. In fact, it probably comprises several different and incompletely characterised disorders.
Visceral hypersensitivity, abnormal gastrointestinal motility, and psychosocial factors are key components of its complex pathophysiology. An aberrant Th2 immune response drives local mucosal microinflammation in one important subgroup of patients. Therefore, a comprehensive diagnostic approach is crucial to management.
Diagnosis and Management of Functional Dyspepsia
Diagnosing functional dyspepsia requires ruling out other organic causes such as peptic ulcer disease or gastric malignancy. Alarm features like unexpected weight loss, vomiting, or age over 60 years necessitate an upper endoscopy. Clinicians recommend a ‘test and treat’ strategy for H. pylori infection for all patients who present with dyspepsia symptoms. The primary focus of management is effective symptom relief.
Currently, there is no single approved drug that cures functional dyspepsia. Treatment remains empirical; therefore, physicians direct it specifically at the dominant symptoms. First-line pharmacological options often include acid suppressants, such as proton pump inhibitors (PPIs) or H2-receptor antagonists. Nevertheless, these are often most effective for patients whose primary complaint is epigastric pain or burning.
For patients with persistent symptoms, a second-line approach often incorporates neuromodulators. Low-dose tricyclic antidepressants (TCAs) are efficacious in reducing overall dyspepsia symptoms, especially by blocking neuronal pain pathways. Moreover, physicians may use prokinetic agents to enhance gastroduodenal motility, particularly in patients with postprandial distress syndrome.
Functional Dyspepsia Overlap Syndromes and Comprehensive Care
Functional dyspepsia frequently overlaps with other gastrointestinal syndromes. Specifically, there is considerable overlap with Irritable Bowel Syndrome (IBS) and Gastroesophageal Reflux Disease (GERD). Patients with these overlap syndromes tend to have more frequent and severe symptoms. Consequently, they often report a poorer health-related quality of life and may be less responsive to standard acid-suppression therapy.
Successful long-term management requires a multidisciplinary approach. In addition to pharmacotherapy, appropriate nutritional and psychological support is essential. Physicians should advise patients to implement lifestyle changes. For example, eating smaller, more-frequent meals and avoiding known trigger foods can help. Furthermore, psychotherapeutic interventions, including cognitive behavioral therapy and hypnotherapy, are beneficial for managing symptoms and the associated anxiety or depression. Encourage patients to engage in regular aerobic exercise.
Frequently Asked Questions
Q1: What is Functional Dyspepsia (FD)?
Functional Dyspepsia is a chronic functional gastrointestinal disorder (now classified as a Disorder of Gut-Brain Interaction) characterized by symptoms such as epigastric pain, early satiety, or postprandial fullness, without any structural or biochemical disease found on testing.
Q2: Which other GI syndromes frequently overlap with FD?
The condition commonly overlaps with Irritable Bowel Syndrome (IBS) and Gastroesophageal Reflux Disease (GERD). Patients with this overlap often experience more severe and complex symptoms.
Q3: What non-drug treatments are part of the management plan for FD?
Non-pharmacological management includes dietary modifications (smaller, frequent meals), appropriate nutritional support, regular aerobic exercise, and psychological support therapies like cognitive behavioral therapy or hypnotherapy.
References
- Pasricha PJ et al. Functional Dyspepsia. N Engl J Med. 2026 Jan 08. doi: 10.1056/NEJMcp2501860. PMID: 41499733.
- Mayo Clinic. Functional dyspepsia – Diagnosis and treatment. (2025-01-04).
- British Society of Gastroenterology guidelines on the management of functional dyspepsia. BMJ. (2022).
- Talley NJ. Functional Dyspepsia: Evaluation and Management. AAFP. (2020-01-15).
- Functional Dyspepsia. StatPearls – NCBI Bookshelf. NIH.
- Gwee KA, Lee YY. Asia-Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal Symptoms. J Gastroenterol Hepatol. (2022).